Vyome Holdings Inc (HIND) - Earnings growth in current year

Corporate emblem and logo of reshapelifesciences.com (HIND)

Vyome Holdings Inc bases its success on a combination of antibacterial developments and weight management systems. Year-over-year EPS dynamics visualize this process, while the 86.70 metric confirms the current level. Price growth potential depends on the effectiveness of new topical agents; however, liquidity shortages and post-asset restructuring complexities create significant operational risks.

HIND - Vyome Holdings Inc Earnings growth in current year over the range 08/16/2025 - 11/18/2026

Comprehensive metric breakdowns and analytics for Vyome Therapeutics (HIND)

- price and consensus price forecast:
Basic company analysis:HIND Vyome Therapeutics
Finished products of ReShape Lifesciences

This indicator determines the dynamics of net income per share, allowing for an assessment of the issuer's solvency by comparing current earnings with the debt load. The formula measures the annual growth rate of EPS, revealing hidden cash flow dips within the fundamental valuation. By analyzing the comparison of EPS with the same period last year, the investor can see the efficiency of clinical research outsourcing while Vyome Holdings Inc (HIND) maintains full control over its intellectual property.

Main competitors

Net earnings per share growth this year argenx SE|Net earnings per share growth this year BNTX|Earnings growth in current year Abivax SA|Earnings per share growth in current year ADMA Bio (ADMA)|Protagonist - Earnings per share growth this year|Earnings growth in current year IMVT (immunovant.com)|Kiniksa Corp (KNSA) - Earnings per share growth rate in current year|Grifols Biemat - Earnings growth in current year|ADPT - Earnings growth in current year|CLDX: Earnings growth in current year|Aurinia Pharmaceuticals Inc (AUPH) - Earnings growth in current year|Earnings per share growth in current year biocryst.com|VERA: Earnings per share increase in current year|Earnings per share growth in current year Dianthus Therapeutics, Inc. (DNTH)|PHVS (Pharvaris) - Earnings per share increase in current year|Earnings per share growth in current year AbCellera ABCL|TRML - Net earnings per share growth this year|Precigen Inc - Earnings growth in current year|Expected net earnings per share growth this year Pharming Corp PHAR|NKTR (Nektar Therapeutics) - Net earnings per share growth this year|Net earnings per share growth this year Upstream Bio|ZBIO (Zenas Bio) - Earnings growth in current year|Earnings per share growth rate in current year Immunome Corp IMNM|Net earnings per share growth this year GOSS (Gossamer Corp)|KALV (KalVista Corp) - Earnings per share increase in current year|Earnings growth in current year SEPN (septerna.com)|Earnings growth in current year pieris.com PVLA|SVRA: Net earnings per share growth this year|Rigel Pharmaceuticals, Inc. (RIGL) - Net earnings per share growth this year|ANAB: Earnings growth in current year|Astria Corp (ATXS) - Earnings growth in current year|Earnings per share growth in current year enGene|Earnings growth in current year RAPT Therapeutics|Earnings growth in current year JBIO|ACRS: Earnings per share trend in current year|Earnings growth in current year KYTX (kyvernatx.com)|TLSA - Net earnings per share growth this year|CABA - Earnings per share growth in current year|Ventyx Biosciences (VTYX) - Net earnings per share growth this year|Theratechnologies, Inc. (THTX) - Earnings per share growth in current year|Net earnings per share growth this year Avalo Therapeutics, Inc.|ELDN (Eledon Pharmaceuticals, Inc) - Earnings growth in current year|Agenus, Inc (AGEN) - Expected net earnings per share growth this year|Earnings growth in current year CLYM|ZURA (Zura Bio Limited) - Earnings per share increase in current year|Earnings per share growth in current year aTyr Pharma ATYR|ADAG - Net earnings per share growth this year|IMA - Earnings per share growth in current year|Shattuck Labs - Net earnings per one share growth for the current year|EQ: Earnings growth in current year|Earnings per share trend in current year CNTB (Connect Biopharma Holdings)|Net earnings per share growth this year IMUX|ATRA (atarabio.com) - Net earnings per one share growth for the current year|Earnings growth in current year IFRX|Earnings growth in current year X4 Pharma (XFOR)|Adicet Bio Inc. - Net earnings per share growth this year|Earnings growth in current year celularity.com CELU|INMB: Net earnings per share growth this year|BRNS: Earnings per share growth in current year|KZR: Earnings growth in current year|SAB Biotherapeutics Inc - Earnings per share increase in current year|AKTX (Akari Therapeutics, Plc) - Earnings growth in current year|ENLV: Earnings per share increase in current year|Earnings per share growth in current year Q32 Bio (QTTB)|Net earnings per share growth this year GeoVax Labs GOVX|Earnings growth in current year EDSA (Edesa Biotech Corp)|iBio, Inc. (IBIO) - Earnings per share growth rate in current year|CARM: Net earnings per share growth this year|XTL Biopharmaceuticals (XTLB) - Net earnings per share growth this year|BOLT: Earnings growth in current year|Net earnings per share growth this year HCW Biologics Inc.|Earnings per share growth in current year aptevotherapeutics.com|AIM: Earnings per share increase in current year|Earnings per share growth in current year aditxt.com (ADTX)|GRI - Earnings per share growth rate in current year|Earnings growth in current year XRTX (XORTX Therapeutics Inc)|REVB - Net earnings per share growth this year|INDP: Net earnings per share growth this year|Earnings per share increase in current year SCNI (Scinai)|CALI: Earnings growth in current year|Affimed NV - Earnings per share increase in current year|ALLK (Allakos) - Earnings growth in current year|Earnings per share growth rate in current year hookipapharma.com HOOK|Earnings growth in current year IGMS|ITOS - Earnings per share growth rate in current year|Earnings growth in current year OCEA (oceanbiomedical.com)|Net earnings per one share growth for the current year TCBP (TC Biopharm)|THRD: Net earnings per share growth this year